pre-IPO PHARMA

chondrial-therapeutics PRESS RELEASE ARCHIVE

Feb 6, 2017

Chondrial Therapeutics Secures Up to $22.6 Million in Series A Financing and Licenses Novel Technology for the Treatment of Friedreich's Ataxia


Google Analytics Alternative